Form D Explorer
Magnus Medical, Inc. · CIK 2057312

Report a data issueCitable research briefCompare issuerPrivate research collection

Magnus Medical, Inc.

CIK 2057312 · Corporation · Inc. DELAWARE · BURLINGAME, California · Biotechnology

These Form D notices describe private placements reported to the SEC. Read Form D/A amendments alongside the original disclosures.

Filing history at a glance

The reported amount sold was $23,683,674 in the May 12, 2025 filing and $49,030,035 in the May 26, 2026 filing. The two records may concern different offerings. From Mar 14, 2025 to May 26, 2026, the explorer stores 2 original notices and 1 amendments.

Filings
3
Original notices
2
Amendments
1
Activity
Mar 14, 2025
through May 26, 2026

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Differences between reported disclosures

Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.

Unavailable values are shown as a dash; reported zero remains zero.
FieldMay 12, 2025 · DMay 26, 2026 · D/ALater minus earlier
Reported offering amount$77,000,000$77,000,000$0
Reported amount sold$23,683,674$49,030,035$25,346,361
Reported investor count—10—
Reported minimum investment$0$0$0

Earlier SEC source: 0002057312-25-000002 · Later SEC source: 0002057312-26-000002

Choose filings to compare · Research this issuer step by step

Latest available filing snapshot: how to read these fields

Form D/A · May 26, 2026

Reported offering amount
$77,000,000
Reported exemptions
Rule 506(b)
Reported amount sold
$49,030,035

This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.

Filings by year

Submission counts, including amendments; not dollars raised or distinct funding rounds.

Form D filings (3)